Tubulin Inhibitors: A Patent Survey

E-ISSN： 2212-3970|9|2|176-220

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.9, Iss.2, 2014-05, pp. : 176-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerases and Tubulin Inhibitors: A Promising Combination for Cancer Treatment

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 6, 2003-11 ,pp. : 421-429

Bentham Science Publishers

Access to resources Recommend Favorite

Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 336-347

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Hybrids- A Patent Survey

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 303-339

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1325-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase I and II Inhibitors: A Patent Review

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 401-423

Bentham Science Publishers

Access to resources Recommend Favorite